![]()
|
|
||||||||
J. Biol. Chem., Vol. 281, Issue 10, 6136-6143, March 10, 2006
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||







1
2
2
234
From the
Fundación Instituto Leloir, Av. Patricias Argentinas 435, 1405 Buenos Aires, Argentina,
Laboratorio de Fisiología y Biología Molecular, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, 1428 Buenos Aires, Argentina, and ¶Molecular Medicine Group, School of Biological Sciences, University of Liverpool, Liverpool L69 3BX, United Kingdom
Leukemia inhibitory factor (LIF) and oncostatin M (OSM) induce DNA synthesis in Swiss 3T3 cells through common signaling mechanism(s), whereas other related cytokines such as interleukin-6 and ciliary neurotrophic factor do not cause this response. Induction of DNA replication by LIF or prostaglandin F2
(PGF2
) occurs, in part, through different signaling events. LIF and OSM specifically trigger STAT1 cytoplasmic to nuclear translocation, whereas PGF2
fails to do so. However, LIF and PGF2
can trigger increases in ERK1/2 activity, which are required for their mitogenic responses because U0126, a MEK1/2 inhibitor, prevents both ERK1/2 activation and induction of DNA synthesis by LIF or PGF2
treatment. PGF2
induces cyclin D expression and full phosphorylation of retinoblastoma protein. In contrast, LIF fails to promote increases in cyclin D mRNA/protein levels; consequently, LIF induces DNA synthesis without promoting full phosphorylation of retinoblastoma protein (Rb). However, both LIF and PGF2
increase cyclin E expression. Furthermore, LIF mitogenic action does not involve protein kinase C (PKC) activation, because a PKC inhibitor does not block this effect. In contrast, PKC activity is required for PGF2
mitogenic action. More importantly, the synergistic effect between LIF and PGF2
to promote S phase entry is independent of PKC activation. These results show fundamental differences between LIF- and PGF2
-dependent mechanism(s) that induce cellular entry into S phase. These findings are critical in understanding how LIF and other related cytokine-regulated events participate in normal cell cycle control and may also provide clues to unravel crucial processes underlying cancerous cell division.
Received for publication, May 27, 2005 , and in revised form, October 7, 2005.
* This work was supported in part by the Association for International Cancer Research Grant 099-018 (Scotland, UK) and Cancer and Polio Research Fund (Liverpool, UK) (to L. J. A. and P. S. R.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 Recipient of a GlaxoSmithKline-Argentina fellowship.
2 Investigator of the National Research Council (CONICET) of Argentina.
4 Visiting Professor from the Royal Society of London, School of Biological Sciences University of Liverpool, Liverpool, UK.
3 To whom correspondence should be addressed: Fundación Instituto Leloir, Av. Patricias Argentinas 435, C1405BWE Buenos Aires, Argentina. Tel.: 54-11-5238-7500; Fax: 54-11-5238-7501; E-mail: Ljimeneza{at}leloir.org.ar.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
W. Li, C.-L. Wu, P. G. Febbo, and A. F. Olumi Stromally Expressed c-Jun Regulates Proliferation of Prostate Epithelial Cells Am. J. Pathol., October 1, 2007; 171(4): 1189 - 1198. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |